Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Frontiers in Microbiology|June 6, 2018
Teicoplanin - Tigecycline Combination Shows Synergy Against Mycobacterium abscessusDinah B Aziz, Jeanette W P Teo, Véronique Dartois, et al.
Expert Opinion on Drug Discovery|April 7, 2023
PROTAC antibiotics: the time is nowJickky Palmae Sarathy, Courtney C Aldrich, Mei-Lin Go, et al.
Microbiology Spectrum|September 8, 2023
Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycinsUday S Ganapathy, Tian Lan, Véronique Dartois, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosisSrinivasa P S Rao, Sylvie Alonso, Lucinda Rand, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial InfectionsDereje A Negatu, Wassihun Wedajo Aragaw, Julianna Cangialosi, et al.
FEMS Microbiology Reviews|October 12, 2021
Critical discussion on drug efflux in Mycobacterium tuberculosisSille Remm, Jennifer C Earp, Thomas Dick, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Rifabutin Is Active against Mycobacterium abscessus in MiceThomas Dick, Sung Jae Shin, Won-Jung Koh, et al.
Microbiology Spectrum|November 15, 2022
Redox Cycling Dioxonaphthoimidazoliums Disrupt Iron Homeostasis in Mycobacterium bovis Bacillus Calmette-GuérinMing Li, Yoshiyuki Yamada, G Marcela Rodriguez, et al.
Antibiotics (Basel, Switzerland)|January 28, 2026
Loss-of-Function Mutations in the Penicillin-Binding Protein PonA1 Confer Agar-Dependent Resistance to Durlobactam in Mycobacterium abscessusDereje Abate Negatu, Wassihun Wedajo Aragaw, Min Xie, et al.
Pageof 17